D-1528-2016 Class III Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-1528-2016 was initiated by Pfizer Inc. on Sep 15, 2016 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date: Bottles were incorrectly labeled with an expiry date of 11/17; the correct date is 09/17. The recall status is terminated (terminated Aug 9, 2017). Affected quantity: 1,316 bottles (1,316,000 tablets).

Recall details

Product Type
Drugs
Report Date
Oct 5, 2016
Initiation Date
Sep 15, 2016
Termination Date
Aug 9, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,316 bottles (1,316,000 tablets)

Product description

PREMARIN (conjugated estrogen tablets, USP) 1.25 mg, 1000- count bottle, Rx only, Distributed by: Wyeth Pharmaceuticals Inc. A subsidiary of Pfizer Inc. Philadelphia, PA 19101, NDC 0046-1104-91

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date: Bottles were incorrectly labeled with an expiry date of 11/17; the correct date is 09/17.

Distribution pattern

Nationwide

Code information

Lot # M35953S; Exp. 11/17 (labeled).

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1528-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1528-2016. Report a data issue: hello@regdatalab.com.